Ithos Regulatory Surveillance Report – Q4 2025
Streamline Cosmetic Regulatory Compliance Without the Guesswork
Download the Ithos Regulatory Surveillance Report – Q4 2025 to see the latest proposed changes across 20+ markets worldwide.
A Snapshot of Global Regulatory Shifts
In the Q4 2025 Ithos Regulatory Surveillance Report, our regulatory experts break down the most significant proposed and enacted changes across key global markets. This quarter reflects intensified scrutiny around CMR classifications, PFAS bans, ingredient scheduling, halal logistics, and evolving labeling standards.
Inside the report, you’ll find concise, practical summaries from Europe, North America, Latin America, Asia-Pacific, and the Middle East, giving your regulatory and R&D teams the clarity needed to prepare portfolios, reformulate proactively, and safeguard market access in 2026 and beyond.Key Highlights From Q4 2025
Andean Community
Eases labeling rules by permitting supplementary stickers for post-approval amendments while formally prohibiting TPO and DMPT in cosmetic products to align with global safety standards.
ASEAN Region
Updates the Cosmetic Directive Annexes, revising and expanding restricted and prohibited substance lists to maintain regulatory alignment with evolving EU requirements.
Canada
Proposes toxic designations for manganese and select flame retardants while strengthening restrictions on PHMB under the Cosmetic Ingredient Hotlist. At the same time, confirms the continued safe use of commonly used alcohols such as isopropanol and propylene glycol.
China
Transitions away from the “special use” classification for categories including hair removal and deodorants, and introduces new technical guidelines standardizing ingredient function claims and plant-derived raw material naming conventions.
European Union
Advances the 24th Adaptation to Technical Progress (ATP), which could lead to the prohibition of ingredients such as tea tree oil if classified as CMR. Enforcement of the EU Deforestation Regulation (EUDR) has been postponed to late 2026/2027, providing brands additional time for supply chain due diligence.
United States
Under MoCRA, the FDA clarifies its mandatory recall authority and evaluates Bemotrizinol as a potential new OTC sunscreen active ingredient. At the state level, jurisdictions such as Connecticut are advancing independent PFAS bans and labeling mandates beginning in 2026.
…and detailed updates from 20+ other jurisdictions worldwide.
Download the Full Report
Get the complete picture of proposed regulatory changes in the global cosmetics industry. Don’t wait until updates become law; equip your team with insights to act now.